Cell Analysis Market worth $23.0 Billion by 2018, according new study on ASDReports

Tuesday 20 May 2014, Amsterdam

A new report on the Cell Analysis Market, available on ASDReports, analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and the Rest of the World (RoW).

This report studies the global cell analysis market over the forecast period of 2013 to 2018. The global cell analysis market was valued at an estimated $16.7 billion in 2013 and is expected to reach $23.0 billion by 2018, growing at a CAGR of 6.6% from 2013 to 2018.

Enhanced accuracy of cell imaging and analysis systems helps in reducing the time and costs involved in the drug discovery process. This is a major factor driving the growth of the cell analysis market. Furthermore, the market is witnessing significant technological innovations and continuous improvements in cell analysis instruments and consumables for applications such as cell identification, cell proliferation, and target toxicity studies. This is another factor propelling the growth of this market. Corporate and government support for the growth of innovative technologies and rising demand for outsourcing of drug discovery services, especially in the Asia-Pacific region, are also the major reasons for the high-growth of this market. Based on cell analysis products, the consumables market commanded the largest share of ~65.5% in 2013. However, the cell analysis instruments market is poised to grow at the highest CAGR from 2013 to 2018.

Based on geography, the global cell analysis market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest share of the market in 2013. This large share of the North American region can be attributed to the presence of government funding and various collaborations among prominent players for developing and marketing new products in the market.

The major players in the cell analysis market include BD Biosciences (U.S.), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), GE Healthcare (U.K.), Olympus (Japan), Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Merck KGaA (Germany), and Promega (U.S).